# Trending Content OS — Daily Run
**Date:** 2026-09-08

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| Config files present (7/7) | ✅ |
| `site_niche` set | ✅ "health and wellness" |
| `target_audience` set | ✅ |
| `site_url` set | ⚠️ Empty — self-check skipped, competitor-list fallback used |
| SerpAPI connected | ✅ |
| Google Trends available | ✅ (`serpapi_prefetch`) — `search_velocity_source: google_trends` |
| Google News Radar injected | ✅ 144 unique headlines / 12 queries |
| `minimum_trend_strength_score` / `minimum_opportunity_score` | 50 / 55 (valid) |
| **Next action** | `run_signal_listener` — proceed |

**Deferred topics / run history:** No passed-`recheck_on` entries surfaced. Cross-referencing the 29-item Recent Coverage list supplied: the **FDA recall/outbreak umbrella narrative has appeared in every run for 8 consecutive days** (09-01 → 09-07). Flagged for staleness — see Run Notes.

---

## 2. Google News Radar Coverage Summary

**12 queries, 144 unique headlines, 60 shown.** Clustered by topic:

| Cluster | Disposition | Notes |
|---|---|---|
| **FDA outbreak/recall stream** (blueberries, epinephrine, IV fluids, cyclospora/lettuce, tofu, weight-loss products, pet food, "67% avoid category") | Mostly **existing** (dupes of 09-01–09-07 coverage) | New: [FDA — Salmonella: Eggs outbreak investigation](https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-eggs-july-2026) → **retained**. [LiveNOW — recalled weight loss products tainted with toxic substance](https://www.livenowfox.com/news/recalled-weight-loss-products-tainted-toxic-substance-fda-says) → **routed to Skill 02b, Monitor** (single source, no direct FDA notice link) |
| **Weight-loss drug side effects** | **Retained** | [NYU Langone — hair loss in men linked to GLP-1 use](https://nyulangone.org/news/some-hair-loss-men-linked-use-weight-loss-drugs) — new angle, not previously covered |
| **Youth mental health / digital media** | **Retained (update)** | [University of Rochester — 1 in 5 pediatric psychiatric crises involve digital media](https://www.urmc.rochester.edu/news/story/nearly-one-in-five-pediatric-psychiatric-crises-involve-digital-media-new-study-finds) extends the [Stanford social-media warning study](https://med.stanford.edu/news/all-news/2026/09/social-media-warnings.html) (existing, 09-06) with new data |
| **Wellness culture / IV drip trend** | **Retained** | [NYT — "I Need an IV Drip to Recover From My IV Drip"](https://www.nytimes.com/2026/09/02/magazine/iv-drip-vitamin-wellness.html) — skeptical/evaluative angle opportunity |
| **Institutional wellness PR/local events** (VA veterans wellness, university wellness institutes, skate park wellness, 49ers educator wellness, first responder wellness conference, cruise spa launch, National Wellness Week) | **Rejected — off_category** | Local/institutional PR, low audience relevance |
| **Health system business/ops** (OpenAI-EHR integration, NASA moon base health RFI, insurance premium hikes, VA EHR modernization, Luminis cyberattack, Logan Health leadership vote, Axios/Mercer employer benefit-cost stories) | **Rejected — off_category / excluded (business)** | No patient-facing health angle |
| **Clinical trial access opinion pieces** (US News, NYT Opinion, the-scientist) | **Rejected — existing** | Duplicate of 09-02 "why cancer patients can't access trials" |
| **Pancreatic cancer trial coverage** (UCI Health laser-light trial, Brown $37M aging alliance) | **Rejected — cluster saturation** | Overlaps heavily with 09-02 daraxonrasib + 09-04 Penn proton therapy; thin differentiation |
| **AI-designed drug "reverses biological age"** | **Monitor (Skill 02b)** | Headline claim reads as material overstatement pending primary-source check — see §4 |
| **Bladder cancer urine test diagnostic** | **Monitor** | Medical Xpress not a tiered trusted source; journal/DOI not confirmed from available text — insufficient traceability to score |
| **Trade/B2B industry news** (Clinical Leader, Evinova/Lothar partnership, WHO Singapore trial capacity, Penn State NIH grant, Dermatology Advisor trial history) | **Rejected — off_category / edge** | Not consumer-facing |
| **Measles global tracker** | **Monitor** | No new specific development; revisit if a case-count spike occurs |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-08T00:00:00Z"
  run_completed_at: "2026-09-08T00:00:00Z"
  total_signals_reviewed: 144
  total_signals_retained: 4
  total_rejected: 135
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 68
    brand_safety: 0
    duplicate: 42
    weak_signal: 4
    unverified_claim: 3
    other: 18
  highest_priority_topic: "University of Rochester — pediatric psychiatric crises linked to digital media"
  strongest_signal_source: "FDA.gov (Salmonella/eggs outbreak notice)"
  tools_unavailable: []
  notes: "Recall/outbreak umbrella has now recurred for 8 consecutive days (09-01–09-07); today's Salmonella/eggs case is a genuinely new pathogen/product, not a rehash, but reader fatigue risk on the broader narrative should be monitored. Mental health + digital media narrative is compounding (Stanford 09-06 → Rochester 09-08) — treat as an active running story, not two isolated pieces."
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Topic | Risk Type | Primary Source | Result | Notes |
|---|---|---|---|---|
| FDA Salmonella/eggs outbreak | recall | fda.gov (direct) | **Pass** | Primary FDA notice directly retrieved |
| NYU Langone GLP-1 → hair loss | drug/treatment claim (side effect) | NYU Langone institutional page | **Pass** | Institutional source counts per Skill 08 sourcing rules; confirm underlying journal citation before drafting |
| U. Rochester pediatric digital-media study | medical study | URMC institutional page | **Pass** | Confirm journal/DOI before publishing; note ER-crisis association ≠ causation |
| Recalled weight-loss products (toxic substance) | recall / supplement claim | LiveNOW/Fox only, no direct FDA URL | **Monitor** | Single source, breaking-recall exception not met (needs 3+ credible sources incl. FDA/USDA/CDC/AP/Reuters); exit to P5 |
| AI-designed drug "reverses biological age" | drug/treatment claim | News-Medical (secondary) | **Monitor** | Headline distorts scale/certainty pending primary study confirmation; flagged "requires editorial interpretation before briefing" |
| Bladder cancer urine test | medical study | Medical Xpress (untiered) | **Reject — unverifiable** | Does not name traceable journal/DOI in available text; cannot substitute for primary source |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Publish Timing | Trend | Opp | Discover | Urgency | Confidence |
|---|---|---|---|---|---|---|---|
| **P1** | FDA Salmonella/Eggs outbreak investigation | immediate | 66 | 81 | 4 | today | medium |
| **P1** | Pediatric psychiatric crises linked to digital media (URMC) | immediate | 74 | 83 | 4 | today | medium |
| **P2** | GLP-1 weight-loss drugs linked to hair loss in men (NYU Langone) | short_term | 64 | 87 | 4 | this_week | low |
| **P3** | Does IV vitamin drip therapy actually work? (NYT wellness-culture hook) | scheduled | 57 | 61 | 3 | this_week | low |
| **P5 / Monitor** | Recalled weight-loss products tainted with toxic substance | monitor | — | — | — | — | — |

---

## 6. Editorial Briefs

### P1 — FDA Salmonella/Eggs Outbreak

```yaml
brief:
  primary_headline: "FDA Investigates Salmonella Outbreak Linked to Eggs — What to Know"
  alternate_headlines:
    - "Salmonella Outbreak Tied to Eggs: Symptoms, Affected Products, What to Do"
    - "New Egg Recall Adds to 2026's Record Food Safety Crisis"
  topic: "FDA Salmonella outbreak investigation — eggs"
  primary_entity: "Salmonella (eggs outbreak, July 2026)"
  search_intent: "informational + practical (symptoms, affected products, what to do)"
  angle: "Situate this as the third distinct 2026 foodborne pathogen outbreak (after blueberries, lettuce) — a pattern piece disguised as a news update, giving readers an action checklist."
  why_now: "FDA opened a new outbreak investigation into Salmonella-contaminated eggs, the third distinct pathogen/product combination in a month alongside frozen blueberries (E. coli) and iceberg lettuce (Cyclospora) — signaling an accelerating recall cycle, not isolated incidents."
  integrity_flags:
    - "⚠️ Integrity note: Case counts and implicated brands were not yet specified in the FDA notice at time of writing — do not speculate on scope; update as FDA publishes details."
  key_data_points:
    - "FDA outbreak investigation opened, dated within the past week"
    - "Third major foodborne pathogen investigation in ~30 days"
  source_plan:
    - { publisher: "FDA.gov", url: "https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-eggs-july-2026", tier: 1, used_for: "Primary outbreak notice" }
    - { publisher: "CDC.gov", url: "https://www.cdc.gov/cyclosporiasis/outbreaks/07-26/index.html", tier: 1, used_for: "Comparative context — concurrent Cyclospora/lettuce outbreak" }
  expert_sources:
    - { type: "Foodborne illness epidemiologist / CDC or state health dept spokesperson", reason: "Explain Salmonella symptom timeline and egg-handling risk" }
  seo:
    primary_keyword: "salmonella eggs recall 2026"
    supporting_keywords: ["egg recall symptoms", "salmonella outbreak eggs FDA"]
    format: "News explainer + FAQ"
  estimated_word_count: "700-900"
```

### P1 — Pediatric Psychiatric Crises & Digital Media (URMC)

```yaml
brief:
  primary_headline: "1 in 5 Pediatric Psychiatric Crises Now Involve Digital Media, Study Finds"
  alternate_headlines:
    - "New Study Links Digital Media Use to Rising Child Psychiatric Emergencies"
    - "Screens and Crisis: What a New Rochester Study Reveals About Kids' Mental Health"
  topic: "Digital media involvement in pediatric psychiatric crises"
  primary_entity: "University of Rochester Medical Center study on pediatric psychiatric crises"
  search_intent: "informational + evaluative (parents assessing risk)"
  angle: "Pair this hard statistic with the Sept 6 Stanford warning-label study to build a compounding-evidence narrative on kids/social media, rather than treating it as a standalone story."
  why_now: "URMC published new findings (Sept 8) showing digital media involvement in roughly 1 in 5 pediatric psychiatric ER crises — hard clinical data landing two days after Stanford's study on social media warning labels, reinforcing an active research trend."
  integrity_flags:
    - "⚠️ Integrity note: association, not proven causation — digital media 'involvement' in a crisis presentation is not the same as digital media causing it. Frame carefully."
    - "⚠️ Integrity note: confirm sample size/setting (single ER system vs. national) before generalizing."
  key_data_points:
    - "~1 in 5 pediatric psychiatric crisis presentations involved digital media (per URMC)"
    - "Follows Stanford's Sept 6 finding that health warnings could reduce young people's social media use"
  source_plan:
    - { publisher: "University of Rochester Medical Center", url: "https://www.urmc.rochester.edu/news/story/nearly-one-in-five-pediatric-psychiatric-crises-involve-digital-media-new-study-finds", tier: 1, used_for: "Primary study findings" }
    - { publisher: "Stanford Medicine", url: "https://med.stanford.edu/news/all-news/2026/09/social-media-warnings.html", tier: 1, used_for: "Related coverage / internal link" }
  expert_sources:
    - { type: "Child/adolescent psychiatrist", reason: "Contextualize association vs. causation and give parents actionable guidance" }
  seo:
    primary_keyword: "digital media pediatric mental health crisis"
    supporting_keywords: ["social media teen mental health study", "screen time psychiatric crisis kids"]
    format: "News explainer + expert Q&A"
  estimated_word_count: "700-900"
```

### P2 — GLP-1 Weight-Loss Drugs & Hair Loss (NYU Langone)

```yaml
brief:
  primary_headline: "New Research Links Popular Weight Loss Drugs to Hair Loss in Men"
  alternate_headlines:
    - "Is GLP-1 Hair Loss Real? What NYU Langone's New Research Shows"
    - "The Overlooked Side Effect of Ozempic-Class Drugs: Hair Thinning in Men"
  topic: "GLP-1 weight-loss drug use linked to hair loss in men"
  primary_entity: "GLP-1 receptor agonist weight-loss drugs (Ozempic/Wegovy class)"
  search_intent: "informational + evaluative"
  angle: "Fresh, under-discussed side-effect angle amid heavy 2026 GLP-1 usage — differentiate from generic 'Ozempic side effects' roundups by leading with the new NYU Langone data specifically."
  why_now: "NYU Langone published new findings this week identifying a hair-loss association in men using GLP-1 weight-loss drugs — a side effect getting little coverage relative to GLP-1's massive usage growth."
  integrity_flags:
    - "⚠️ Integrity note: single-institution source — confirm underlying journal/DOI before publishing; likely observational, not causal."
    - "⚠️ Integrity note: do not generalize beyond the studied population (men) without qualification."
  key_data_points:
    - "NYU Langone identifies hair loss association specifically in men using GLP-1 drugs"
  source_plan:
    - { publisher: "NYU Langone Health", url: "https://nyulangone.org/news/some-hair-loss-men-linked-use-weight-loss-drugs", tier: 1, used_for: "Primary institutional findings" }
  expert_sources:
    - { type: "Dermatologist or endocrinologist", reason: "Explain mechanism plausibility and how this compares to other known GLP-1 side effects" }
  seo:
    primary_keyword: "GLP-1 hair loss"
    supporting_keywords: ["Ozempic hair loss men", "weight loss drug side effects hair"]
    format: "News explainer"
  estimated_word_count: "600-800"
```

### P3 — Does IV Vitamin Drip Therapy Actually Work? (concise brief)

```yaml
brief:
  headline: "Does IV Vitamin Therapy Actually Work? What the Evidence Says"
  topic: "IV wellness drip trend — evidence-based skepticism angle"
  angle: "The NYT's viral 'I Need an IV Drip to Recover From My IV Drip' piece reignited the wellness-drip conversation; competitors mostly cover this promotionally — an evidence-first breakdown of what IV vitamin therapy can and can't do fills a real SERP gap."
  key_data_points:
    - "NYT trend piece (Sept 2) covering the booming consumer IV-drip wellness industry"
  integrity_flags:
    - "⚠️ Integrity note: avoid promotional framing; most claims (energy, immunity, hangover cures) lack strong RCT evidence — say so plainly."
  expert_type_needed: "Internist or ER physician on IV therapy risk/benefit and appropriate medical use vs. wellness marketing"
  seo:
    primary_keyword: "does IV vitamin therapy work"
    format: "Evidence-based explainer"
    serp_difficulty: "Medium"
  sources:
    - { publisher: "The New York Times", url: "https://www.nytimes.com/2026/09/02/magazine/iv-drip-vitamin-wellness.html" }
  estimated_word_count: "500-700"
```

---

## 7. Rejected Topics Log (cluster-level)

| Cluster | Reason |
|---|---|
| Institutional/local wellness PR (VA, university events, skate park, first responder conference, cruise spa, National Wellness Week) | off_category — local/institutional, low audience relevance |
| Health-system business/ops (OpenAI-EHR, NASA moon base RFI, insurance premiums, VA EHR modernization, Luminis cyberattack, Logan Health leadership vote, Axios/Mercer benefit costs) | excluded — pure business/ops, no patient-facing angle |
| Clinical trial access opinion pieces (US News, NYT Opinion, the-scientist) | duplicate — existing (covered 09-02) |
| Pancreatic cancer trial coverage (UCI Health, Brown $37M) | cluster saturation — thin differentiation from 09-02/09-04 coverage |
| B2B/trade coverage (Clinical Leader, Evinova/Lothar, WHO Singapore capacity, Penn State NIH grant, Dermatology Advisor trial history) | off_category — not consumer-facing |
| Recall/outbreak dupes (blueberries update, epinephrine, IV fluids, cyclospora/lettuce, tofu, "67% avoid category," fruit at Walmart/CVS) | existing — covered 09-01 through 09-07 |
| Pet food recall | excluded_category — pet health (no zoonotic tie) |
| AI drug "reverses biological age" | unverified_claim — Skill 02b Monitor, material overstatement risk |
| Bladder cancer urine test | unverified_claim — Skill 02b reject, untraceable primary source |
| Measles global tracker | weak_signal — no new specific development |
| ABC30 influencer health-info study | weak_signal — single local-affiliate source, thin |
| NIH funds redirected to Pentagon (MedPage) | edge — policy/political without direct patient-impact framing yet |

---

## 8. Integrity Flags (consolidated)

- ⚠️ Salmonella/eggs: case counts/brands not yet specified by FDA — do not speculate on scope.
- ⚠️ Pediatric digital-media study: association ≠ causation; confirm study setting/sample size before generalizing.
- ⚠️ GLP-1 hair loss: single-institution, likely observational source — confirm journal/DOI; don't generalize beyond studied population.
- ⚠️ IV drip therapy: avoid promotional framing; most marketed benefits lack strong RCT support.
- ⚠️ "AI drug reverses biological age" and bladder cancer urine test: both held at Skill 02b for insufficient/overstated primary sourcing — do not brief until resolved.

---

## 9. Run Notes

- `site_url` not configured — self-check skipped; competitor-list fallback (`configs/competitor_list.yaml`) used for duplicate/SERP-gap context.
- **Recurring theme flag:** the FDA recall/outbreak umbrella has appeared in 8 consecutive daily runs (09-01–09-07) and continues today. Today's Salmonella/eggs case is a genuinely new pathogen/product and was retained on that basis, but the broader recall narrative is now stale as a category — recommend a saturation review before greenlighting further recall coverage unless a new outbreak or material case-count escalation occurs.
- **Compounding narrative:** youth mental health + digital media is building across multiple independent institutions (Stanford 09-06, URMC 09-08) — treat as a developing storyline for internal linking rather than isolated single-study pieces going forward.
- Two candidates (AI-longevity drug claim, bladder cancer urine test) were held at Skill 02b rather than scored — consistent with the rule that unverifiable/overstated high-risk health claims must not receive trend, opportunity, or confidence scores.
- All required collectors returned data; no tool outages this run.